Assessment of long non-coding RNA expression reveals novel mediators of the lung tumour immune response

[1]  H. Yao,et al.  Association of Long Noncoding RNA Biomarkers With Clinical Immune Subtype and Prediction of Immunotherapy Response in Patients With Cancer , 2020, JAMA network open.

[2]  Xia Li,et al.  Pan-cancer characterization of immune-related lncRNAs identifies potential oncogenic biomarkers , 2020, Nature Communications.

[3]  Congcong Yan,et al.  Identification of tumor immune infiltration-associated lncRNAs for improving prognosis and immunotherapy response of patients with non-small cell lung cancer , 2020, Journal for ImmunoTherapy of Cancer.

[4]  Hubing Shi,et al.  Long Non-coding RNAs: Emerging Roles in the Immunosuppressive Tumor Microenvironment , 2020, Frontiers in Oncology.

[5]  K. Syrigos,et al.  Nivolumab plus Ipilimumab in Advanced Non-Small-Cell Lung Cancer. , 2019, The New England journal of medicine.

[6]  W. Lam,et al.  Aberrant Expression of Pseudogene-Derived lncRNAs as an Alternative Mechanism of Cancer Gene Regulation in Lung Adenocarcinoma , 2019, Front. Genet..

[7]  Norbert Mercier,et al.  Response to Comment on “The earliest modern humans outside Africa” , 2018, Science.

[8]  J. Lunceford,et al.  Pan-tumor genomic biomarkers for PD-1 checkpoint blockade–based immunotherapy , 2018, Science.

[9]  W. Lam,et al.  Somatic mutation-associated T follicular helper cell elevation in lung adenocarcinoma , 2018, Oncoimmunology.

[10]  P. Carmeliet,et al.  Phenotype molding of stromal cells in the lung tumor microenvironment , 2018, Nature Medicine.

[11]  G. Calin,et al.  Long non-coding RNAs within the tumour microenvironment and their role in tumour-stroma cross-talk. , 2018, Cancer letters.

[12]  S. Novello,et al.  Pembrolizumab plus Chemotherapy in Metastatic Non–Small‐Cell Lung Cancer , 2018, The New England journal of medicine.

[13]  Stephen Broderick,et al.  Neoadjuvant PD‐1 Blockade in Resectable Lung Cancer , 2018, The New England journal of medicine.

[14]  E. Amir,et al.  HYPE or HOPE: the prognostic value of infiltrating immune cells in cancer , 2018, British Journal of Cancer.

[15]  Jun S. Liu,et al.  TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells. , 2017, Cancer research.

[16]  O. Schwartz,et al.  HEXIM1 and NEAT1 Long Non-coding RNA Form a Multi-subunit Complex that Regulates DNA-Mediated Innate Immune Response. , 2017, Molecular cell.

[17]  Ludmila V. Danilova,et al.  Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade , 2017, Science.

[18]  E. Amir,et al.  HYPE or HOPE: the prognostic value of infiltrating immune cells in cancer , 2017, British Journal of Cancer.

[19]  Daniel R. Caffrey,et al.  Immunobiology of Long Noncoding RNAs. , 2017, Annual review of immunology.

[20]  C. Benoist,et al.  Flicr, a long noncoding RNA, modulates Foxp3 expression and autoimmunity , 2017, Proceedings of the National Academy of Sciences.

[21]  M. Atkins,et al.  Predictive biomarkers for checkpoint inhibitor-based immunotherapy. , 2016, The Lancet. Oncology.

[22]  Y. Shentu,et al.  Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer. , 2016, The New England journal of medicine.

[23]  Patrick Danaher,et al.  Gene expression markers of Tumor Infiltrating Leukocytes , 2016, Journal of Immunotherapy for Cancer.

[24]  Charles H. Yoon,et al.  Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq , 2016, Science.

[25]  A. Butte,et al.  Systematic pan-cancer analysis of tumour purity , 2015, Nature Communications.

[26]  Maite Huarte.  The emerging role of lncRNAs in cancer , 2015, Nature Medicine.

[27]  L. Zitvogel,et al.  Meta-analysis of organ-specific differences in the structure of the immune infiltrate in major malignancies , 2015, Oncotarget.

[28]  Martin L. Miller,et al.  Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer , 2015, Science.

[29]  D. Schadendorf,et al.  Nivolumab in previously untreated melanoma without BRAF mutation. , 2015, The New England journal of medicine.

[30]  Peter S. Linsley,et al.  Copy Number Loss of the Interferon Gene Cluster in Melanomas Is Linked to Reduced T Cell Infiltrate and Poor Patient Prognosis , 2014, PloS one.

[31]  Xuetao Cao,et al.  The STAT3-Binding Long Noncoding RNA lnc-DC Controls Human Dendritic Cell Differentiation , 2014, Science.

[32]  Howard Y. Chang,et al.  Long Noncoding RNAs: Cellular Address Codes in Development and Disease , 2013, Cell.

[33]  Jeannie T. Lee,et al.  Long Noncoding RNAs: Past, Present, and Future , 2013, Genetics.

[34]  Howard Y. Chang,et al.  The NeST Long ncRNA Controls Microbial Susceptibility and Epigenetic Activation of the Interferon-γ Locus , 2013, Cell.

[35]  A. Feeney,et al.  Noncoding transcription within the Igh distal VH region at PAIR elements affects the 3D structure of the Igh locus in pro-B cells , 2012, Proceedings of the National Academy of Sciences.

[36]  Rui-Ru Ji,et al.  An immune-active tumor microenvironment favors clinical response to ipilimumab , 2012, Cancer Immunology, Immunotherapy.

[37]  Emily A. Vucic,et al.  Human Cancer Long Non-Coding RNA Transcriptomes , 2011, PloS one.

[38]  Carolyn J. Brown,et al.  The functional role of long non-coding RNA in human carcinomas , 2011, Molecular Cancer.

[39]  Lunxu Liu,et al.  The number and microlocalization of tumor-associated immune cells are associated with patient's survival time in non-small cell lung cancer , 2010, BMC Cancer.

[40]  Cole Trapnell,et al.  Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. , 2010, Nature biotechnology.

[41]  J. Mattick,et al.  Long non-coding RNAs: insights into functions , 2009, Nature Reviews Genetics.

[42]  N. Kedersha,et al.  Characterization of GMP-17, a granule membrane protein that moves to the plasma membrane of natural killer cells following target cell recognition. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[43]  Ash A. Alizadeh,et al.  SUPPLEMENTARY NOTE , 1879, Botanical Gazette.

[44]  R. Kurokawa,et al.  Long Noncoding RNAs , 2015, Springer Japan.

[45]  Thomas R. Gingeras,et al.  STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..

[46]  D. Spector,et al.  The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells. , 2013, Cancer research.

[47]  J. Townsend,et al.  NIH Public Access Author Manuscript , 2006 .

[48]  D. Holdstock.  Past, present--and future? , 2005, Medicine, conflict, and survival.

[49]  F H Bach,et al.  Characterization of a novel gene (NKG7) on human chromosome 19 that is expressed in natural killer cells and T cells. , 1993, Human immunology.